Evaluating the cost-effectiveness of clinical and public health measures.

Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost-effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.

[1]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[2]  A. Muller.  Evaluation of the costs and benefits of motorcycle helmet laws. , 1980, American journal of public health.

[3]  L. Goldman,et al.  Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. , 1987, American journal of public health.

[4]  D. B. Kamerud.  Benefits and costs of the 55 mph speed limit: New estimates and their implications , 1988 .

[5]  D. Eddy.  Screening for breast cancer. , 1989, Annals of internal medicine.

[6]  Gordon S. Smith,et al.  COST OF INJURY IN THE UNITED STATES: A REPORT TO CONGRESS , 1989 .

[7]  D. Viano,et al.  Injury impairment and disability scales to assess the permanent consequences of trauma. , 1990, Accident; analysis and prevention.

[8]  D. Eddy.  Screening for cervical cancer. , 1990, Annals of internal medicine.

[9]  L. Goldman,et al.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. , 1990, JAMA.

[10]  F. Sonnenberg,et al.  Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. , 1990, Annals of internal medicine.

[11]  Max Henrion,et al.  Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis , 1990 .

[12]  D. Eddy,et al.  Screening for colorectal cancer , 1992, The Lancet.

[13]  K. Freedberg,et al.  Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. , 1991, Journal of acquired immune deficiency syndromes.

[14]  M. Weinstein,et al.  Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. , 1991, The New England journal of medicine.

[15]  L. Goldman,et al.  Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. , 1991, JAMA.

[16]  M. Johannesson,et al.  Economic evaluation in health care: is there a role for cost-benefit analysis? , 1991, Health policy.

[17]  M. Fahs,et al.  Cost Effectiveness of Cervical Cancer Screening for the Elderly , 1992, Annals of Internal Medicine.

[18]  L J Blincoe,et al.  The economic cost of motor vehicle crashes, 1990 , 1992 .

[19]  B. Hillner,et al.  Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results. , 1992, JAMA.

[20]  M. Drummond,et al.  Cost-effectiveness league tables: more harm than good? , 1993, Social science & medicine.

[21]  F. Marcinowski,et al.  Reducing the risks from radon. , 1993, Air & waste : journal of the Air & Waste Management Association.

[22]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  D. Thompson,et al.  Cost-effectiveness analysis of bicycle helmet subsidies in a defined population. , 1993, Pediatrics.

[24]  F. Sonnenberg,et al.  Who should be screened for HIV infection? A cost-effectiveness analysis. , 1993, Archives of internal medicine.

[25]  A. Detsky,et al.  Should Canada and the United States Universally Vaccinate Infants against Hepatitis B? , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  B. Hillner,et al.  The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Birkmeyer,et al.  The cost‐effectiveness of preoperative autologous blood donation for total hip and knee replacement , 1993, Transfusion.

[28]  B. Bloom,et al.  A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness Analysis , 1993, Annals of Internal Medicine.

[29]  M. Halloran,et al.  Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.

[30]  J. Birkmeyer,et al.  Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. , 1994, JAMA.

[31]  I. Cameron,et al.  Cost effectiveness of accelerated rehabilitation after proximal femoral fracture. , 1994, Journal of clinical epidemiology.

[32]  S. Cantor,et al.  Cost-effectiveness analysis of screening health care workers for HIV. , 1994, The Journal of family practice.

[33]  J. Birkmeyer,et al.  Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. , 1994, The Annals of thoracic surgery.

[34]  P. Scuffham,et al.  The cost-effectiveness of compulsory bicycle helmets in New Zealand. , 2010, Australian journal of public health.

[35]  R. Francis,et al.  A comparison of the effectiveness and cost of treatment for vertebral fractures in women. , 1995, British journal of rheumatology.

[36]  B. Hillner,et al.  Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[38]  J. Graham,et al.  The cost effectiveness of three programs to increase use of bicycle helmets among children. , 1995, Public health reports.

[39]  Tammy O. Tengs,et al.  Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[40]  T R Miller,et al.  DATABOOK ON NONFATAL INJURY: INCIDENCE, COSTS, AND CONSEQUENCES , 1995 .

[41]  J. Kanis,et al.  Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium. , 1995, QJM : monthly journal of the Association of Physicians.

[42]  A. Williams,et al.  The prospects of daytime running lights for reducing vehicle crashes in the United States. , 1995, Public health reports.

[43]  C. J. Rosenquist,et al.  The cost-effectiveness of mammographic screening strategies. , 1995, JAMA.

[44]  M. Hunink,et al.  Triage of patients to angiography for detection of aortic rupture after blunt chest trauma: cost-effectiveness analysis of using CT. , 1995, AJR. American journal of roentgenology.

[45]  M. Drummond,et al.  Assessment of health producing measures across different sectors. , 1995, Health policy.

[46]  Ruth E. Brown,et al.  Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. , 1995, JAMA.

[47]  M. Pauly.  Valuing health care: Valuing health care benefits in money terms , 1995 .

[48]  Patricia Scott,et al.  Screening Surgeons for HIV Infection: A Cost-effectiveness Analysis , 1995, Annals of Internal Medicine.

[49]  R. Shew,et al.  An economic analysis of child restraints , 1995 .

[50]  S. Kleinman,et al.  Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study , 1995, Transfusion.

[51]  E. Mackenzie,et al.  The development of the Functional Capacity Index. , 1996, The Journal of trauma.

[52]  L. Goldman,et al.  Cost-effectiveness of routine coronary angiography after acute myocardial infarction. , 1996, Circulation.

[53]  K. Freedberg,et al.  Validating Literature-based Models with Direct Clinical Trial Results , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[54]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[55]  D. Owens,et al.  Cost-effectiveness of HIV screening in acute care settings. , 1996, Archives of internal medicine.

[56]  M. Devivo,et al.  Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation. , 1996, Archives of physical medicine and rehabilitation.

[57]  David R. Holtgrave,et al.  Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. , 1996, American journal of public health.

[58]  J. Weigelt,et al.  Blunt thoracic aortic trauma. A cost-utility approach for injury detection. , 1996, Archives of surgery.

[59]  L. Goldman,et al.  Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. , 1997, Circulation.

[60]  D. Mark,et al.  Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. , 1997, The New England journal of medicine.

[61]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine , 1997 .

[62]  L. Goldman,et al.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. , 1997, JAMA.

[63]  David R. Holtgrave,et al.  Cost‐effectiveness of HIV‐prevention skills training for men who have sex with men , 1997, AIDS.

[64]  M. Weinstein,et al.  The cost-effectiveness of air bags by seating position. , 1997, JAMA.

[65]  M. Johannesson,et al.  Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. , 1997, The New England journal of medicine.